Full Press Release Details
TARRYTOWN, N.Y.,Sept. 1, 2016/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast a management presentation at the following investor conferences:
• 2016 Credit Suisse Antibody Day at10:00 a.m. Eastern TimeonWednesday, September 7, 2016
• Morgan Stanley Global Healthcare Conference at11:40 a.m. Eastern TimeonMonday, September 12, 2016
• Bank of America Merrill Lynch Global Healthcare Conference at6:25 a.m. Eastern TimeonWednesday, September 14, 2016
The sessions may be accessed through the Company's web site,www.regeneron.com, on the 'Events and Presentations' page. An archived version of the presentation will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.Regeneron is a leading science-based biopharmaceutical company based inTarrytown, New Yorkthat discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. For additional information about the Company, please visitwww.regeneron.comor follow @Regeneron on Twitter.
Investor Relations Corporate CommunicationsManisha Narasimhan, Ph.D. Hala Mirza914.847.5126 914.847.3422[email protected][email protected]